One Year Efficacy and Safety Results of a Phase II Trial of Secukinumab in Patients with Rheumatoid Arthritis.

被引：0

作者：

Genovese, Mark C. ^{[1
]}

Durez, Patrick ^{[2
]}

Richards, Hanno B. ^{[3
]}

Supronik, Jerzy ^{[4
]}

Dokoupilova, Eva ^{[5
]}

Aelion, Jacob A. ^{[6
]}

Lee, Sang-Heon ^{[7
]}

Codding, Christine E. ^{[8
]}

Kellner, Herbert ^{[9
]}

Ikawa, Takashi ^{[10
]}

Hugot, Sophie ^{[3
]}

Ligozio, Gregory ^{[11
]}

Mpofu, Shephard ^{[3
]}

机构：

[1] Stanford Univ, Palo Alto, CA 94304 USA

[2] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium

[3] Novartis Pharma AG, Basel, Switzerland

[4] NZOZ Ctr Med Artur Racewicz, Bialystok, Poland

[5] Med Plus Sro, Uherske Hradiste, Czech Republic

[6] Arthrit Clin, Jackson, TN USA

[7] Konkuk Univ Med Ctr, Seoul, South Korea

[8] Hlth Res Oklahoma, Oklahoma City, OK USA

[9] Ctr Inflammatory Joint Dis, Munich, Germany

[10] Kobe Konan Yamate Clin, Kobe, Hyogo, Japan

[11] Novartis Pharmaceut, E Hanover, NJ USA

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

401

引用

页码：S149 / S150

页数：2

共 50 条

[31] Therapeutic trial with type II oral collagen in rheumatoid arthritis. [J].

Neira, O ;

Alvarado, A ;

Cerda, C ;

Guzman, L ;

Abumohor, P ;

Basualdo, J ;

Palma, S ;

Fuentealba, C .

ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :394-394

[32] EFFICACY AND SAFETY OF SECUKINUMAB TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS [J].

Kriulin, I. ;

Alexeeva, E. ;

Dvoryakovskaya, T. ;

Isaeva, K. ;

Chomakhidze, A. ;

Chistyakova, E. ;

Lomakina, O. ;

Denisova, R. ;

Mamutova, A. ;

Fetisova, A. ;

Gautier, M. ;

Vankova, D. ;

Krekhova, E. ;

Shingarova, M. ;

Alshevskaya, A. ;

Moskalev, A. .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 :485-485

[33] Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized, Placebo-Controlled Trial Of Golimumab In Methotrexate-naive Patients With Rheumatoid Arthritis [J].

Emery, Paul ;

Fleischmann, Roy M. ;

Strusberg, Ingrid ;

Durez, Patrick ;

Nash, Peter ;

Amante, Eric ;

Churchill, Melvin A. ;

Park, Won ;

Pons-Estel, Bernardo ;

Han, Chenglong ;

Gathany, Timothy A. ;

Zhou, Yiying ;

Xu, Stephen ;

Hsia, Elizabeth C. .

ARTHRITIS AND RHEUMATISM, 2013, 65 :S188-S189

[34] FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS [J].

Emery, Paul ;

Fleischmann, Roy M. ;

Strusberg, Ingrid ;

Durez, Patrick ;

Nash, Peter ;

Amante, Eric ;

Churchill, Melvin ;

Park, W. ;

Pons-Estel, Bernardo ;

Han, Chenglong ;

Gathany, Tim ;

Zhou, Yiying ;

Xu, Stephen ;

Hsia, Elizabeth C. .

RHEUMATOLOGY, 2014, 53 :93-93

[35] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5-YEAR EFFICACY AND SAFETY RESULTS FROM THE FUTURE 1 PHASE 3 TRIAL [J].

Tahir, Hasan ;

Mease, Philip J. ;

Kavanaugh, Arthur ;

Reimold, Andreas ;

Rech, Juergen ;

Hall, Stephen ;

Geusens, Piet ;

Pellet, Pascale ;

Delicha, Eumorphia Maria ;

Pricop, Luminita ;

Mpofu, Shephard .

RHEUMATOLOGY, 2019, 58 :151-151

[36] 5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial [J].

Marzo-Ortega, Helena ;

Sieper, Joachim ;

Kivitz, Alan J. ;

Blanco, Ricardo ;

Cohen, Martin ;

Pavelka, Karel ;

Delicha, Eumorphia M. ;

Stefanska, Anna ;

Richards, Hanno B. ;

Rohrer, Susanne .

LANCET RHEUMATOLOGY, 2020, 2 (06) :E339-E346

[37] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL [J].

Mease, P. J. ;

Kavanaugh, A. ;

Reimold, A. ;

Tahir, H. ;

Rech, J. ;

Hall, S. ;

Geusens, P. ;

Pascale, P. ;

Delicha, E. M. ;

Pricop, L. ;

Mpofu, S. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :952-953

[38] SAFETY AND EFFICACY OF ATACICEPT IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ATACICEPT FOR REDUCTION OF SIGNS AND SYMPTOMS IN RHEUMATOID ARTHRITIS TRIAL (III) [J].

van Vollenhoven, R. F. ;

Wax, S. ;

Copt, S. ;

Tak, P. P. .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 :183-184

[39] Long-term efficacy and safety of meloxicam in juvenile rheumatoid arthritis. [J].

Foeldvari, I ;

Burgos-Vargas, R ;

Thon, A .

ARTHRITIS AND RHEUMATISM, 2000, 43 (09) :S121-S121

[40] Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial [J].

van Vollenhoven, Ronald F. ;

Keystone, Edward Clark ;

Strand, Vibeke ;

Pacheco-Tena, Cesar ;

Vencovsky, Jiri ;

Behrens, Frank ;

Racewicz, Arthur ;

Zipp, Daniela ;

Rharbaoui, Faiza ;

Wolter, Ralf ;

Knierim, Luise ;

Schmeidl, Rainer ;

Zhou, Xuefei ;

Aigner, Silke ;

Daelken, Benjamin ;

Wartenberg-Demand, Andrea .

ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (04) :495-499

← 1 2 3 4 5 →